SCHEMBL1695337

SCHEMBL1695337

CSCC[C@H](NC=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 1/20 0.57
FPR1 P21462 4/20 0.54
FPR2 P25090 4/20 0.54
NPY1R P25929 1/20 0.53
NPY2R P49146 1/20 0.53
NPY4R P50391 1/20 0.53
ACE P12821 5/20 0.51
FNTA P49354 3/20 0.48
FNTB P49356 3/20 0.48
MME P08473 1/20 0.47
CPA1 P15085 1/20 0.47
ACE2 Q9BYF1 1/20 0.47
IL1RN P18510 1/20 0.46
ERAP2 Q6P179 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1695336 1.00 FOLH1 (0.57) FOLH1FPR1FPR2NPY1RNPY2R
SCHEMBL27066381 0.99 FOLH1 (0.56) FOLH1FPR1FPR2NPY1RNPY2R
SCHEMBL27066401 0.99 FOLH1 (0.56) FOLH1FPR1FPR2NPY1RNPY2R
SCHEMBL27066379 0.99 FOLH1 (0.56) FOLH1FPR1FPR2NPY1RNPY2R
SCHEMBL27066371 0.96 FPR1 (0.56) FOLH1FPR1FPR2NPY1RNPY2R
SCHEMBL27066397 0.96 FPR1 (0.56) FOLH1FPR1FPR2NPY1RNPY2R
SCHEMBL27066369 0.96 FPR1 (0.56) FOLH1FPR1FPR2NPY1RNPY2R
SCHEMBL27066398 0.96 FPR1 (0.56) FOLH1FPR1FPR2NPY1RNPY2R
SCHEMBL27066400 0.96 FPR1 (0.56) FOLH1FPR1FPR2NPY1RNPY2R
SCHEMBL27066357 0.96 FPR1 (0.56) FOLH1FPR1FPR2NPY1RNPY2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119152050-A Geometric point cloud compression method based on multi-scale multi-level convertors 西安邮电大学 2024-12-17 CN claimed
CN-118707703-A Large aperture ratio zoom lens 株式会社适马 2024-09-27 CN claimed
US-20260115302-A1 TUMOR-SPECIFIC CLEAVABLE LINKERS XILIO DEV INC (US) 2026-04-30 US disclosed
US-12280120-B2 Tumor-specific cleavable linkers Xilio Development, Inc. (US) 2025-04-22 US disclosed
US-20250111889-A1 DE NOVO DESIGNED MACROCYCLIC OLIGOAMIDES UNIVERSITY OF WASHINGTON 2025-04-03 US disclosed
US-20250101075-A1 MASKED IL-2 CYTOKINES AND METHODS OF USE THEREOF Xilio Development, Inc. 2025-03-27 US disclosed
US-20250092109-A1 VHH MASKED CYTOKINES AND METHODS OF USE THEREOF Xilio Development, Inc. 2025-03-20 US disclosed
CN-119152050-A Geometric point cloud compression method based on multi-scale multi-level convertors 西安邮电大学 2024-12-17 CN disclosed
CN-118707703-A Large aperture ratio zoom lens 株式会社适马 2024-09-27 CN disclosed
US-20230365641-A1 TARGETED CYTOKINES AND METHODS OF USE THEREOF Xilio Development, Inc. 2023-11-16 US disclosed
US-20230331799-A1 MASKED IL-15 CYTOKINES AND THEIR CLEAVAGE PRODUCTS Xilio Development, Inc. 2023-10-19 US disclosed
EP-4126246-A2 MASKED IL-15 CYTOKINES AND THEIR CLEAVAGE PRODUCTS Xilio Development, Inc. (US) 2023-02-08 EP disclosed
EP-4126249-A1 MASKED IL-12 CYTOKINES AND THEIR CLEAVAGE PRODUCTS Xilio Development, Inc. (US) 2023-02-08 EP disclosed
US-20230003280-A1 SEAMLESS ADHESIVE JOINTS AND MECHANICAL BELTS INCLUDING SEAMLESS ADHESIVE JOINTS SAINT-GOBAIN PERFORMANCE PLASTICS CORPORATION 2023-01-05 US disclosed
WO-2022272223-A1 SEAMLESS ADHESIVE JOINTS AND MECHANICAL BELTS INCLUDING SEAMLESS ADHESIVE JOINTS SAINT-GOBAIN PERFORMANCE PLASTICS CORPORATION (US) 2022-12-29 WO disclosed
US-20150118178-A1 CONJUGATES COMPRISING AN N-OXIME BOND AND ASSOCIATED METHODS UNIV KANSAS (US) 2015-04-30 US disclosed
US-8956604-B2 Conjugates comprising an N-oxime bond and associated methods THE UNIVERSITY OF KANSAS (US) 2015-02-17 US disclosed
US-20130195791-A1 CONJUGATES COMPRISING AN N-OXIME BOND AND ASSOCIATED METHODS THE UNIVERSITY OF KANSAS 2013-08-01 US disclosed
EP-2585108-A1 CONJUGATES COMPRISING AN N-OXIME BOND AND ASSOCIATED METHODS University Of Kansas (US) 2013-05-01 EP disclosed
WO-2011163568-A1 CONJUGATES COMPRISING AN N-OXIME BOND AND ASSOCIATED METHODS UNIVERSITY OF KANSAS (US) 2011-12-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130195791-A1 CONJUGATES COMPRISING AN N-OXIME BOND AND ASSOCIATED METHODS DOHH, HCCS, PRMT1 FOLH1 586/4885FPR1 255/4885FPR2 397/4885
US-20230331799-A1 MASKED IL-15 CYTOKINES AND THEIR CLEAVAGE PRODUCTS IL15, IL15RA, IL5 FOLH1 707/4885FPR1 540/4885FPR2 390/4885
US-20250111889-A1 DE NOVO DESIGNED MACROCYCLIC OLIGOAMIDES DHFR, CCNH, ODC1 FOLH1 374/4885FPR1 1757/4885FPR2 1384/4885
US-20150118178-A1 CONJUGATES COMPRISING AN N-OXIME BOND AND ASSOCIATED METHODS DOHH, HCCS, PRMT1 FOLH1 586/4885FPR1 255/4885FPR2 397/4885
US-20260115302-A1 TUMOR-SPECIFIC CLEAVABLE LINKERS SPPL2B, SPPL2A, CTSL FOLH1 33/4885FPR1 286/4885FPR2 92/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.